Company profile: CordenPharma
1.1 - Company Overview
Company description
- Provider of contract development and manufacturing services to pharmaceutical and biotechnology companies, including APIs with development, scale-up and regulatory support; non-sterile and sterile drug products (oral solids, liquids, lyophilized); synthetic lipid excipients (standard and custom); peptide development and manufacturing; and support for bioavailability, LNP formulation/manufacturing, and packaging.
Products and services
- Drug Products: Engineers pharmaceutical-grade non-sterile and sterile dosage forms, constructing oral solids, liquids, and lyophilized products using technologies suited for oral, sterile, highly potent, and antibiotic applications
- APIs: Produces scalable active pharmaceutical ingredients for various drug formulations, building precise molecular components to serve as the pharmacologically active basis within finished oral, sterile, and antibiotic pharmaceuticals
- Lipid Excipients: Supplies custom-engineered synthetic lipid excipients for drug formulation, offering a range of standard and custom lipids to architect excipient components compatible with specific pharmaceutical products
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to CordenPharma
Multi-Specialty Research Associates
HQ: United States
Website
- Description: Provider of Phase I-IV clinical trial services across a wide range of therapeutic areas, including vaccine research for Covid-19 and other infectious diseases, delivered from its north Florida office and backed by more than 50 years of combined research experience.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Multi-Specialty Research Associates company profile →
Jean Brown Research
HQ: United States
Website
- Description: Provider of clinical research site management services, conducting post-operative pain studies for pharmaceutical companies. With 30+ years of experience in pain management protocols, vaccine testing, and phase I-IV studies, JBR operates two facilities near Salt Lake City, Utah and trains staff in patient interaction to deliver accurate, detailed study results using proprietary training.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jean Brown Research company profile →
Open Health
HQ: United Kingdom
Website
- Description: Provider of medical communications, omni, HEOR, and market access services, including market access strategy; health economic modeling and meta-analysis; patient engagement; patient-centered outcomes; real-world evidence and data analytics; medical affairs consultancy and strategy; publications planning and delivery; scientific communications; and learning and development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Open Health company profile →
Alphora Research
HQ: Canada
Website
- Description: Provider of FDA-approved full-service CRDMO solutions focused on process chemistry, cGMP scale-up, and analytical method development for complex small-molecule APIs. Services include drug substance and product development for biologics and small molecules, preclinical and clinical outsourcing, CDMO manufacturing, and integrated end-to-end support from early development to full-scale manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alphora Research company profile →
Biose
HQ: France
Website
- Description: Provider of pharmaceuticals based on live bacteria, with 60 years of experience and specialized skills across discovery, process development, manufacturing, and registration, focused on health through microbiota and microbiome science.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biose company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for CordenPharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to CordenPharma
2.2 - Growth funds investing in similar companies to CordenPharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for CordenPharma
4.2 - Public trading comparable groups for CordenPharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →